Nasdaq-Listed Coal Miner Adds 425 BTC To Balance Sheet

On a Q1 earnings call yesterday, Alliance Resource Partners, a coal mining company worth $2.8 billion that trades under the ticker ARLP on the Nasdaq, reported that it’s mining bitcoin and currently holding 425 BTC on its balance sheet. Nasdaq listed Alliance Resources $ARLP, a $2.8b coal mining company, is mining #bitcoin, and currently holds…

Read More

Swiss Central Bank Urged to Add Bitcoin to Balance Sheet

A group of Bitcoin advocates in Switzerland have launched a campaign to convince the Swiss National Bank (SNB) to add Bitcoin to its balance sheet.  The nonprofit organization 2B4CH aims to hold a national referendum to amend Switzerland’s constitution to require the central bank to hold Bitcoin. BREAKING: 🇨🇭Bitcoiners to launch a petition for Swiss…

Read More

Hafnia Stock: Healthy Balance Sheet And 19% FCF Yield; Rating Unchanged (OTCMKTS:HAFNF)

Pauws99/iStock Editorial via Getty Images Note: I previously covered Hafnia (OTCQX:HAFNF). In my last take, I discussed the clean tankers market and the company’s strengths (fleet, balance sheet, and attractive dividends). In today’s analysis, I dissect the last earnings report, update Hafnia’s valuation, and review its rating. Fleet Hafnia owns 116 vessels (10 LR2, 31…

Read More

International Money Express: Potentially Undervalued, But With Balance Sheet Risks

Viorika International Money Express (NASDAQ:IMXI) looks like a strong addition to portfolios looking for stable growth and relatively low risk at this time. The company’s shares look undervalued to me despite P/E ratio concerns, and profitability weaknesses could be eased through operational shifts. Operations International Money Express, or Intermex, is a specialist in money remittance…

Read More

Pan American Silver: Diversified Precious Metal Miner With Robust Balance Sheet (PAAS)

La_Corivo Introduction Pan American Silver (NYSE:PAAS) is one of my favorite silver miners. Since Yamana’s acquisition, the company has added quality assets, considerably expanding its reserves and resource base. PAAS assets are in countries with relatively low political risk in the Western Hemisphere. Besides that, the revenue per country does not exceed 25%. 3Q23 production…

Read More

Breaking Down Paramount’s Finances: Not Going Bankrupt But Balance Sheet Could Be Better

Phillip Faraone/Getty Images Entertainment Numbers matter, especially financials. Some in the media are reporting that Paramount (NASDAQ:PARA) doesn’t have enough cash and will go bankrupt next year, neglecting to mention the cash Paramount will get from the Simon & Schuster sale and Paramount’s revolving line of credit. Could Paramount’s balance sheet be a lot better?…

Read More

December’s ECB Cheat Sheet: A Reality Check For Ultra-Dovish Expectations

Andreas Rentz By Francesco Pesole, FX Strategist; Benjamin Schroeder, Senior Rates Strategist ING Heading into the European Central Bank’s December meeting, there is growing evidence that the Governing Council is split about the messaging being presented to markets. The generally arch-hawk Isabel Schnabel dropped strong dovish hints by ruling out rate hikes this week, and…

Read More

Toronto-Dominion: Diversified Bank, Robust Balance Sheet, And Respectable Yields (NYSE:TD)

BalkansCat/iStock Editorial via Getty Images Thesis Toronto-Dominion Bank (NYSE:TD) is the second-largest bank in Canada. Its balance sheet is neat and clean, with adequate liquidity to weather potential economic downturns. Typical for Canadian banks, TD has paid dividends even during crises such as GFC 2008. Its business is well diversified geographically between the US and…

Read More

Hong Kong and Israel Partner with BIS to Test CBDCs That Settle on Central Bank Balance Sheet

According to BIS research, 93% of central banks across the world are investigating the feasibility of issuing CBDCs. The Hong Kong Monetary Authority (HKMA) and the Bank of Israel (BOI) have partnered to address the privacy concerns associated with central bank digital currencies (CBDCs). This is according to a joint report titled “Project Sela –…

Read More

Vir Biotechnology: Strong Balance Sheet But Commercial Prospects Await More Clarity

UmbertoPantalone In late December, I recommended Vir Biotechnology, Inc. (NASDAQ:VIR) as a speculative Buy due to its long-term cash availability, experienced management team, collaborations with significantly large commercial companies such as GSK and progressing pipeline. The company has recently released its Q2 2023 earnings report. Biotechnology firm stocks are hugely sensitive to news updates rather…

Read More